Skip to main content
Icosavax, Inc. (ICVX)
Feb 20, 2024 - ICVX was delisted (reason: acquired by AstraZeneca)
15.31
0.00 (0.00%)
Last trade price

Icosavax Revenue

In the year 2022, Icosavax had annual revenue of $582.00K, a decrease of -92.54%.

Revenue (ttm)
$582.00K
Revenue Growth
-92.54%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
60
Market Cap
766.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022582.00K-7.22M-92.54%
Dec 31, 20217.80M6.19M382.80%
Dec 31, 20201.62M--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ICVX News

More News